MolecuLight Inc. has launched the MolecuLightDX, a new point-of-care device for real-time detection of elevated bacterial burden in wounds. New features on the MolecuLightDX include comprehensive EMR integration options and patient-centric user interface and workflow for wound tracking. The DX enables rapid digital wound measurement for documentation of procedures and wound progression via a stickerless measurement capability which automatically measures wound area. In addition, all MolecuLight procedures in the U.S. benefit from a reimbursement pathway including two CPT codes for physician work for “fluorescence wound imaging for bacterial presence, location, and load” and facility payment for HOPD and ASC settings through an APC assignment.
